Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

222
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
222

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Remote Multicomponent Rehabilitation in Intensive Care Unit Survivors: A Randomized Clinical Trial.

JAMA·2026
Same author

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

The Lancet. Respiratory medicine·2026
Same journal

British Thoracic Society quality standard for pulmonary rehabilitation.

BMJ open respiratory research·2026
Same journal

Maternal, Infant, Reproductive and Child Health in Cystic Fibrosis (MATRIARCH_CF): a prospective, observational study to evaluate pregnancy and parenthood in females with cystic fibrosis and health of the offspring in the CFTR-modulator era.

BMJ open respiratory research·2026
Same journal

Maternal asthma activity and offspring asthma: a linked-data population study in Australia and Sweden.

BMJ open respiratory research·2026
Same journal

Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial.

BMJ open respiratory research·2026
Same journal

GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA).

BMJ open respiratory research·2026
Same journal

Current use and future potential of oscillometry in UK lung function testing: a national survey.

BMJ open respiratory research·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K

ブロンキエクトーシスにおける共同意思決定の改善

Paul McCallion1,2, Judy M Bradley3, Adam Lewis4

  • 1Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK paul.mccallion@nhs.net.

BMJ open respiratory research
|September 3, 2025
PubMed
まとめ
この要約は機械生成です。

ブロンキエクトーシスの個別化医療は拡大している. 共同意思決定 (SDM) は,患者の選択と呼吸道クリアランス技術 (ACT) の遵守を向上させ,非薬学的な治療に不可欠です.

キーワード:
ブロンキエタシス

さらに関連する動画

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

795
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

528

関連する実験動画

Last Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

795
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

528

科学分野:

  • 肺科
  • パーソナライズ された 医療
  • 健康心理学

背景:

  • ブロンキエクタシスは個別の治療を必要とする複雑な肺疾患です.
  • 現在の管理には,呼吸道クリアランス技術 (ACT) のような薬理学的および非薬理学的アプローチが含まれています.
  • 患者のACTへの従順性は変化し,パーソナライゼーションの改善の必要性を強調しています.

研究 の 目的:

  • bronchiectasis の ACT 処方箋のパーソナライゼーションにおける共有意思決定 (SDM) の役割を探求する.
  • SDMが患者の選択とACTの遵守をどのように改善するか調査する.
  • ブロンキエクトーシスにおけるACTのためのSDM介入の開発のステップを概説する.

主な方法:

  • bronchiectasisにおけるパーソナライズド医療とSDMに関する文献レビュー.
  • ACTの処方における現在のガイドラインと課題の議論
  • SDM介入のための概念的枠組み

主要な成果:

  • 既存の文献では,肺管切除症のACT処方における患者の好みに焦点を当てていない.
  • SDMは患者の選択を ACTの選択と遵守に統合するための枠組みを提供します.
  • SDMの介入は 患者の力を高め ACTとの関わり方を改善します

結論:

  • 共同意思決定 (SDM) は, bronchiectasis の呼吸道クリアランス技術 (ACT) をパーソナライズする大きな可能性を秘めています.
  • SDMを実装することで 患者さんを力強くし ACTの重要性を理解し 患者さんの従順性を高めることができます
  • ブロンキエクトーシスにおけるACTに対するSDM介入の開発と評価にはさらなる研究が必要である.